reports
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of ...
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit Company to host conference call and webcast with key opinion leader on December 3, 2024, at 7:30 a.m. ET FREDERICK, Md., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that updated efficacy and safety data from the Phase 2b trial of Descartes-08 in patients...
Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics Announces New Employment Inducement Grants FREDERICK, Md., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of inducement awards to two new employees. On November 4, 2024, the Company issued to these employees options to purchase an aggregate of 4,854 shares of the Company’s common stock with an exercise price of $19.11, the closing trading price of the Company’s common stock on the...
Cartesian Therapeutics Reports Third Quarter 2024 Financial Results an...
Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update Company expects to commence Phase 3 trial of Descartes-08 in patients with myasthenia gravis in 1H2025 following recent meeting with U.S. Food and Drug Administration Presentation of updated efficacy and safety data from Phase 2b trial and Phase 3 trial design of Descartes-08 in patients with myasthenia gravis expected by year-end Dosing underway in Phase 2 trial of Descartes-08 in patients with systemic lupus erythematosus Dosing underway in first-in-human Phase 1 tr...
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH...
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting FREDERICK, Md., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that safety and tolerability data from patients treated with Descartes-08 will be featured during a poster presentation at the upcoming 66th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 7-10, 2024 in San Diego. A copy of the abstract is available...
Cartesian Therapeutics Announces Presentation of Results from Phase 2b...
Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting Company continues to expect to hold an End-of-Phase 2 meeting with the FDA by year-end GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced the presentation of data from its Phase 2b trial of Descartes-08 in patients with generaliz...
Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics Announces New Employment Inducement Grants GAITHERSBURG, Md., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of inducement awards to five new employees. On October 1, 2024, the Company issued to these employees options to purchase an aggregate of 60,961 shares of the Company’s common stock with an exercise price of $17.11, the closing trading price of the Company’s common stock on...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
SPWH SPORTMANS WAREHOUSE HOLDINGS
PSEC PROSPECT CAPITAL CORPORATION
PENN PENN NATIONAL GAMING INC.
PBF PBF ENERGY INC. CLASS A
MTDR MATADOR RESOURCES COMPANY
I3N CHART INDUSTRIES INC.
GLP GLOBAL PARTNERS LP
CRWS CROWN CRAFTS INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CHCT COMMUNITY HEALTHCARE TRUST INCORPORATED
BEN FRANKLIN RESOURCES INC.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
HTLD HEARTLAND EXPRESS INC.
MYRG MYR GROUP INC.
RIGN TRANSOCEAN LTD.
GBDC GOLUB CAPITAL BDC INC.
HLT HILTON WORLDWIDE HOLDINGS INC
APTV APTIV PLC
CLAR CLARUS CORPORATION
APPN APPIAN
CNX CONSOL ENERGY INC.
TALO TALOS ENERGY INC.
TCPC BLACKROCK TCP CAPITAL CORP.
ETON ETON PHARMACEUTICALS
STIM STIMSONITE CORP
ONEW ONEWATER MARINE
ADV ADVANTAGE SOLUTIONS INC (A)
GRNT GRANIT SKOPKE
FTCI FTC SOLAR
INBX INC.
TDUP INHIBRX
FTHY INC.
AMLX THREDUP INC.
CRGY FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
PFHC AMYLYX PHARMACEUTICALS INC
BTSG CRESCENT ENERGY CO
SYRS PROFRAC HLDG CORP
PEO BRIGHTSPRING HEALTH SERVICES INC.
XPER SYROS PHARMACEUTICALS INC.
PETROLEUM & RESOURCES CORPORATION
XPERI INC
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
PSEC PROSPECT CAPITAL CORPORATION
PENN PENN NATIONAL GAMING INC.
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
MTDR MATADOR RESOURCES COMPANY
GLP GLOBAL PARTNERS LP
CIA CITIZENS INC. CL A
GBDC GOLUB CAPITAL BDC INC.
APPN APPIAN
TALO TALOS ENERGY INC.
ONEW ONEWATER MARINE
FTCI FTC SOLAR
SNCY INC.
AMLX SUN COUNTRY AIRLINES HLDGS INC
CRGY AMYLYX PHARMACEUTICALS INC
PFHC CRESCENT ENERGY CO
BENF PROFRAC HLDG CORP
BENEFICIENT
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation...
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis IND filing for Phase 2 pediatric basket study on track for year-end GAITHERSBURG, Md., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to Descartes-08 for the treatment of juvenile dermatomyositis (JDM). ...
Cartesian Therapeutics Announces New Employment Inducement Grant
Cartesian Therapeutics Announces New Employment Inducement Grant GAITHERSBURG, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of an inducement award to a new employee. On September 3, 2024, the Company issued to this employee an option to purchase 3,864 shares of the Company’s common stock with an exercise price of $13.12, the closing trading price of the Company’s common stock on the Nasdaq Globa...
- Jonathan Moreland
WSR WHITESTONE REIT
TTSH TILE SHOP HOLDINGS INC.
PSEC PROSPECT CAPITAL CORPORATION
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
CGNX COGNEX CORPORATION
CIA CITIZENS INC. CL A
GBDC GOLUB CAPITAL BDC INC.
TALO TALOS ENERGY INC.
FSLY FASTLY
FTCI FTC SOLAR
AMLX INC.
AMPX AMYLYX PHARMACEUTICALS INC
PEO AMPRIUS TECHNOLOGIES INC
AMWL PETROLEUM & RESOURCES CORPORATION
GDV AMERICAN WELL CORP
THE GABELLI DIVIDEND & INCOME TRUST
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
CECE CECO ENVIRONMENTAL CORP.
GBDC GOLUB CAPITAL BDC INC.
SMRT SMARTSPACE SOFTWARE
TCPC BLACKROCK TCP CAPITAL CORP.
CRTX CORTEXYME
INBX INHIBRX
SUNS INC.
NTG SUNRISE REALTY TRUST
MRAI TORTOISE MIDSTREAM ENERGY FUND INC
MDRR MARPAI
INC.
MEDALIST DIVERSIFIED REIT INC.
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human...
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15 Descartes-15 observed to achieve an approximately ten-fold increase relative to Descartes-08 in CAR expression and selective target-specific killing in preclinical studies GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the first patient has been dosed in its first-in-hum...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
PBF PBF ENERGY INC. CLASS A
OOMA OOMA
MPAA MOTORCAR PARTS OF AMERICA INC.
LANC LANCASTER COLONY CORPORATION
IMMR IMMERSION CORP.
HNRG HALLADOR ENERGY CO.
GLP GLOBAL PARTNERS LP
FLDM FLUIDIGM
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CRK COMSTOCK RESOURCES INC.
BEN FRANKLIN RESOURCES INC.
APEI AMERICAN PUBLIC EDUCATION
ATEC ALPHATEC HOLDINGS INC.
DKL DELEK LOGISTICS PARTNERS
MYRG MYR GROUP INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
GBDC GOLUB CAPITAL BDC INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ISDR ISSUER DIRECT CORP.
AXR AMREP
ELAN ELANCO ANIMAL HEALTH INC.
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
GRWG GROWGENERATION
ONEW ONEWATER MARINE
BILL BILL.COM HOLDINGS
HPK HIGHPEAK ENERGY INC (A)
ABCL ABCELLERA BIOLOGICS
LESL LESLIES
BFLY BUTTERFLY NETWORK INC (A)
INBX INHIBRX
IMMX INC.
NN IMMIX BIOPHARMA INC
NXGL NEXTNAV INC
BIGZ NEXGEL INC
PFHC BLACKROCK INNOVATION AND GROWTH TST
CALC PROFRAC HLDG CORP
ATMU CALCIMEDICA INC.
ET ATMUS FILTRATION TECHNOLOGIES INC
MIO ENERGY TRANSFER LP
PEO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
SUNS PETROLEUM & RESOURCES CORPORATION
XPER SUNRISE REALTY TRUST
OBDE XPERI INC
LOCO OWL ROCK CAPITAL CORP III
LOVE OIL INC.
- Jonathan Moreland
MPAA MOTORCAR PARTS OF AMERICA INC.
LANC LANCASTER COLONY CORPORATION
IMMR IMMERSION CORP.
GLP GLOBAL PARTNERS LP
FLDM FLUIDIGM
CTRN CITI TRENDS INC.
APEI AMERICAN PUBLIC EDUCATION
GBDC GOLUB CAPITAL BDC INC.
BRN BARNWELL INDUSTRIES
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ISDR ISSUER DIRECT CORP.
AXR AMREP
UPWK UPWORK
HPK HIGHPEAK ENERGY INC (A)
ABCL ABCELLERA BIOLOGICS
NVTS NAVITAS SEMICONDUCTOR CORP
PFHC PROFRAC HLDG CORP
SRBK SR BANCORP INC
- Jonathan Moreland
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
HNRG HALLADOR ENERGY CO.
FLDM FLUIDIGM
BEN FRANKLIN RESOURCES INC.
APEI AMERICAN PUBLIC EDUCATION
ATEC ALPHATEC HOLDINGS INC.
DKL DELEK LOGISTICS PARTNERS
BWFG BANKWELL FINANCIAL GROUP
GBDC GOLUB CAPITAL BDC INC.
APPN APPIAN
QNTO QUAINT OAK BANCORP INC.
ELAN ELANCO ANIMAL HEALTH INC.
U UNITY SOFTWARE INC.
ONEW ONEWATER MARINE
INBX INHIBRX
IMMX INC.
PFHC IMMIX BIOPHARMA INC
CALC PROFRAC HLDG CORP
ET CALCIMEDICA INC.
XPER ENERGY TRANSFER LP
NUTX XPERI INC
NUTEX HEALTH INC
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Cartesian Therapeutics to Participate in Upcoming Investor Conferences GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in September: A fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference at 2:30 p.m. ET on Monday, September 9, 2024 in New York, NYA fireside chat at the Cantor Global Healthcare Conference at 9:4...
- Jonathan Moreland
OEC ORION ENGINEERED CARBONS SA
MTDR MATADOR RESOURCES COMPANY
HEAR TURTLE BEACH CORP
FLDM FLUIDIGM
DAR DARLING INGREDIENTS INC.
CRWS CROWN CRAFTS INC.
CRK COMSTOCK RESOURCES INC.
APEI AMERICAN PUBLIC EDUCATION
ATEC ALPHATEC HOLDINGS INC.
PCF PUTNAM HIGH INCOME SECURITIES FUND
LIND LINDBLAD EXPEDITIONS HOLDINGS
YUMC YUM CHINA HOLDINGS INC.
GBDC GOLUB CAPITAL BDC INC.
NNBR NN
MAV INC.
APPN PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI APPIAN
CNX PIONEER MUNICIPAL HIGH INCOME TRUST
SGC CONSOL ENERGY INC.
GRX SUPERIOR GROUP OF COMPANIES
PSNL THE GABELLI HEALTHCARE & WELLNESSRX TRUST
EMYB PERSONALIS
CSU EMBASSY BANCORP INC.
FTCI CAPITAL SENIOR LIVING
INBX FTC SOLAR
BVS INC.
TMCI INHIBRX
TSE INC.
BIGZ BIOVENTUS
PFHC TREACE MED CONCEPTS INC
GRNT TRINSEO PLC
VFC BLACKROCK INNOVATION AND GROWTH TST
SRPT PROFRAC HLDG CORP
LIFW GRANITE RIDGE RESOURCES INC
PROP VF CORPORATION
EYPT SAREPTA THERAPEUTICS
MIO INC.
PYYX MSP RECOVERY INC.
PEO PRAIRIE OPERATING CO.
SUNS EYEPOINT PHARMACEUTICALS
OI INC.
WPC PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
MSGE PYXUS INTERNATIONAL INC
PETROLEUM & RESOURCES CORPORATION
SUNRISE REALTY TRUST
OWENS ILLINOIS INC.
W. P. CAREY AND CO. LLC
MSG ENTERTAINMENT SPINCO
INC.
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
EHTH EHEALTH INC.
CRK COMSTOCK RESOURCES INC.
APEI AMERICAN PUBLIC EDUCATION
LIND LINDBLAD EXPEDITIONS HOLDINGS
GBDC GOLUB CAPITAL BDC INC.
CNX CONSOL ENERGY INC.
NANX NANOPHASE TECHNOLOGIES CORP.
GO GROCERY OUTLET HOLDING
EMYB EMBASSY BANCORP INC.
INBX INHIBRX
BIGZ INC.
PFHC BLACKROCK INNOVATION AND GROWTH TST
GRNT PROFRAC HLDG CORP
LUNR GRANITE RIDGE RESOURCES INC
LIFW INTUITIVE MACHINES INC
MIO MSP RECOVERY INC.
PYYX PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
SUNS PYXUS INTERNATIONAL INC
MSGE SUNRISE REALTY TRUST
MSG ENTERTAINMENT SPINCO
INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.